Speaker illustration

Doctor Takahiro Noto

Sapporo Medical University, Sapporo (Japan)

Early commencement of tolvaptan therapy improves clinical outcomes in heart failure patients with preserved function of renal vasopressin V2 receptors

Event: ESC Congress 2018

Topic: Pharmacotherapy

Session: Chronic heart failure – Treatment

Thumbnail

This platform is supported by

logo Novo Nordisk